Clinical Trial Update: A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 multiple-dose study of Debio 1450 in healthy volunteers (administered intravenously or orally) sponsored by Debiopharm International SA has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• Debio 1450

Snippet

Sponsor: Debiopharm International SA | Conditions: Bacterial Infections | Phase 1 | Status: COMPLETED